Prehospital management of acute respiratory distress in suspected COVID-19 patients

Am J Emerg Med. 2021 Jul:45:410-414. doi: 10.1016/j.ajem.2020.09.022. Epub 2020 Sep 14.

Abstract

Background: In December 2019, coronavirus disease (COVID-19) emerged in China and became a world-wide pandemic in March 2020. Emergency services and intensive care units (ICUs) were faced with a novel disease with unknown clinical characteristics and presentations. Acute respiratory distress (ARD) was often the chief complaint for an EMS call. This retrospective study evaluated prehospital ARD management and identified factors associated with the need of prehospital mechanical ventilation (PMV) for suspected COVID-19 patients.

Methods: We included 256 consecutive patients with suspected COVID-19-related ARD that received prehospital care from a Paris Fire Brigade BLS or ALS team, from March 08 to April 18, 2020. We performed multivariate regression to identify factors predisposing to PMV.

Results: Of 256 patients (mean age 60 ± 18 years; 82 (32%) males), 77 (30%) had previous hypertension, 31 (12%) were obese, and 49 (19%) had diabetes mellitus. Nineteen patients (7%) required PMV. Logistic regression observed that a low initial pulse oximetry was associated with prehospital PMV (ORa = 0.86, 95%CI: 0.73-0.92; p = 0.004).

Conclusions: This study showed that pulse oximetry might be a valuable marker for rapidly determining suspected COVID-19-patients requiring prehospital mechanical ventilation. Nevertheless, the impact of prehospital mechanical ventilation on COVID-19 patients outcome require further investigations.

Publication types

  • Observational Study

MeSH terms

  • Ambulatory Care / methods*
  • COVID-19 / complications
  • COVID-19 / epidemiology*
  • Disease Management*
  • Emergency Medical Services*
  • Follow-Up Studies
  • France / epidemiology
  • Pandemics*
  • Respiration, Artificial / methods*
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy*
  • Retrospective Studies
  • SARS-CoV-2